Jesper Mølgaard

897 total citations
38 papers, 539 citations indexed

About

Jesper Mølgaard is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Jesper Mølgaard has authored 38 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 14 papers in Cardiology and Cardiovascular Medicine and 10 papers in Biomedical Engineering. Recurrent topics in Jesper Mølgaard's work include Hemodynamic Monitoring and Therapy (12 papers), Cardiac, Anesthesia and Surgical Outcomes (9 papers) and Non-Invasive Vital Sign Monitoring (8 papers). Jesper Mølgaard is often cited by papers focused on Hemodynamic Monitoring and Therapy (12 papers), Cardiac, Anesthesia and Surgical Outcomes (9 papers) and Non-Invasive Vital Sign Monitoring (8 papers). Jesper Mølgaard collaborates with scholars based in Denmark, Sweden and United Kingdom. Jesper Mølgaard's co-authors include Anders Olsson, A G Olsson, Claes Lassvik, H. von Schenck, Lone Nikolajsen, Barbara Upson, Anna‐Karin Holm, M.R. Malinow, Christian S. Meyhoff and Eske Kvanner Aasvang and has published in prestigious journals such as European Heart Journal, Arteriosclerosis Thrombosis and Vascular Biology and Sensors.

In The Last Decade

Jesper Mølgaard

35 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesper Mølgaard Denmark 12 331 130 119 98 78 38 539
B. Royston United Kingdom 9 446 1.3× 175 1.3× 217 1.8× 82 0.8× 20 0.3× 16 1.0k
Juha Nissinen Finland 14 317 1.0× 137 1.1× 343 2.9× 37 0.4× 17 0.2× 30 663
Jonathan Weiswasser United States 13 265 0.8× 246 1.9× 181 1.5× 18 0.2× 18 0.2× 24 624
H S Wasir India 17 372 1.1× 173 1.3× 577 4.8× 32 0.3× 18 0.2× 69 863
Wim B. Gerritsen Netherlands 15 193 0.6× 281 2.2× 233 2.0× 11 0.1× 77 1.0× 23 735
Sema Güneri Türkiye 15 286 0.9× 88 0.7× 572 4.8× 14 0.1× 36 0.5× 53 946
Atsushi Okada Japan 13 128 0.4× 94 0.7× 386 3.2× 27 0.3× 42 0.5× 77 635
Weerachai Nawarawong United States 12 370 1.1× 196 1.5× 176 1.5× 96 1.0× 4 0.1× 25 672
John E. Forestner United States 11 408 1.2× 105 0.8× 96 0.8× 137 1.4× 7 0.1× 28 804
Benjamin O’Brien United Kingdom 17 251 0.8× 104 0.8× 403 3.4× 115 1.2× 6 0.1× 80 851

Countries citing papers authored by Jesper Mølgaard

Since Specialization
Citations

This map shows the geographic impact of Jesper Mølgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Mølgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Mølgaard more than expected).

Fields of papers citing papers by Jesper Mølgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Mølgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Mølgaard. The network helps show where Jesper Mølgaard may publish in the future.

Co-authorship network of co-authors of Jesper Mølgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Mølgaard. A scholar is included among the top collaborators of Jesper Mølgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Mølgaard. Jesper Mølgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Olsen, Markus Harboe, et al.. (2024). Prognostic value of heart rate variability for risk of serious adverse events in continuously monitored hospital patients. Journal of Clinical Monitoring and Computing. 38(6). 1315–1329. 2 indexed citations
3.
Mølgaard, Jesper, et al.. (2024). Comparison of Wireless Continuous Axillary and Core Temperature Measurement after Major Surgery. Sensors. 24(14). 4469–4469.
4.
Mølgaard, Jesper, et al.. (2023). Deviating vital signs in continuous monitoring prior to discharge and risk of readmission: an observational study. Internal and Emergency Medicine. 18(5). 1453–1461. 2 indexed citations
5.
Kaas‐Hansen, Benjamin Skov, Anders Granholm, Praleene Sivapalan, et al.. (2023). Real‐world causal evidence for planned predictive enrichment in critical care trials: A scoping review. Acta Anaesthesiologica Scandinavica. 68(1). 16–25. 1 indexed citations
6.
Mølgaard, Jesper, et al.. (2023). Quantifying physiological stability in the general ward using continuous vital signs monitoring: the circadian kernel density estimator. Journal of Clinical Monitoring and Computing. 37(6). 1607–1617. 3 indexed citations
7.
Sørensen, Henrik, Jesper Mølgaard, Nicolai Bang Foss, et al.. (2023). Associations between clinical interventions and transcutaneous blood gas values in postoperative patients. Journal of Clinical Monitoring and Computing. 37(5). 1255–1264. 2 indexed citations
8.
Mølgaard, Jesper, et al.. (2023). The effect of technical filtering and clinical criteria on alert rates from continuous vital sign monitoring in the general ward. Hospital Practice. 51(5). 295–302. 7 indexed citations
10.
Gu, Ying, et al.. (2022). Prediction of serious outcomes based on continuous vital sign monitoring of high-risk patients. Computers in Biology and Medicine. 147. 105559–105559. 19 indexed citations
11.
Porsbjerg, Celeste, Jens‐Ulrik Stæhr Jensen, Jesper Mølgaard, et al.. (2022). Clinical impact of vital sign abnormalities in patients admitted with acute exacerbation of chronic obstructive pulmonary disease: an observational study using continuous wireless monitoring. Internal and Emergency Medicine. 17(6). 1689–1698. 12 indexed citations
12.
Mølgaard, Jesper, et al.. (2022). Prediction of Serious Adverse Events from Nighttime Vital Signs Values. 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). 2022. 2631–2634. 2 indexed citations
13.
Mølgaard, Jesper, et al.. (2021). Ethics in extracorporeal life support: a narrative review. Critical Care. 25(1). 256–256. 10 indexed citations
14.
Gu, Ying, et al.. (2021). Prediction of severe adverse event from vital signs for post-operative patients. 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). 2021. 971–974. 4 indexed citations
15.
Mølgaard, Jesper, M.R. Malinow, Claes Lassvik, et al.. (1992). Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication. Journal of Internal Medicine. 231(3). 273–279. 95 indexed citations
16.
Johansson, Jan, Jesper Mølgaard, & Anders Olsson. (1991). Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia. Atherosclerosis. 91(3). 175–184. 13 indexed citations
17.
Ahlburg, Peter, et al.. (1990). Treatment of pancreatic pain with interpleural bupivacaine: an open trial. Acta Anaesthesiologica Scandinavica. 34(2). 156–157. 18 indexed citations
18.
Mølgaard, Jesper, Martin Carlsson, Jan Nilsson, & Anders Olsson. (1990). Decreased mitogenic activity in hypercholesterolaemic plasma. Journal of Internal Medicine. 227(5). 339–345. 2 indexed citations
19.
Mølgaard, Jesper, H. von Schenck, & Anders Olsson. (1989). Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia. European Journal of Clinical Pharmacology. 36(5). 455–460. 31 indexed citations
20.
Mølgaard, Jesper, H. von Schenck, & A G Olsson. (1988). Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. European Heart Journal. 9(5). 541–551. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026